Laboratory assessment of prostate status.
An obvious advantage of a combined PAP and PSA measurement is the increased sensitivity of detection. Furthermore, the use of both markers in monitoring patients with prostatic carcinoma offers the advantage of a greater number of patients with objective parameters for follow-up.
Saito
Y
Y
Department of Urology, Nagasaki University School of Medicine, Japan.
D000135:Acid Phosphatase / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008297:Male; D011467:Prostate / Q000201:enzymology; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000201:enzymology / Q000276:immunology
D014408:Biomarkers, Tumor; D007527:Isoenzymes; D000135:Acid Phosphatase; D017430:Prostate-Specific Antigen